TALIMOGENE LAHERPAREPVEC

TALIMOGENE LAHERPAREPVEC was reported 1588 times

TALIMOGENE LAHERPAREPVEC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACRAL LENTIGINOUS MELANOMA STAGE II 1 0.2000
1 NUT MIDLINE CARCINOMA 1 0.1667
2 C1Q NEPHROPATHY 1 0.1667
3 URETHRAL MELANOMA METASTATIC 1 0.1667
4 FOLLICLE CENTRE LYMPHOMA DIFFUSE SMALL CELL LYMPHOMA 1 0.1429
5 MELANOSIS 12 0.1071
6 HYPERVITAMINOSIS B12 1 0.0909
7 SCAN BRAIN 1 0.0714
8 MELANOMA RECURRENT 30 0.0713
9 HERPES SIMPLEX SEPSIS 2 0.0690
10 INSERTION OF AMBULATORY PERITONEAL CATHETER 1 0.0625
11 METASTATIC MALIGNANT MELANOMA 115 0.0500
12 SCAN 1 0.0476
13 ACOUSTIC NEURITIS 1 0.0455
14 POSITRON EMISSION TOMOGRAM 1 0.0417
15 ACHROMOTRICHIA ACQUIRED 2 0.0408
16 DESMOPLASTIC MELANOMA 1 0.0370
17 PERIPHERAL NERVE SHEATH TUMOUR MALIGNANT 1 0.0333
18 LYMPH NODE HAEMORRHAGE 1 0.0303
19 DISSEMINATED HERPES SIMPLEX 2 0.0270
20 HERPES SIMPLEX TEST POSITIVE 5 0.0251
21 LYMPHADENITIS VIRAL 1 0.0250
22 SCLERAL OEDEMA 2 0.0241
23 RADICAL MASTECTOMY 1 0.0213
24 TUMOUR ULCERATION 5 0.0211
25 POLYMERASE CHAIN REACTION POSITIVE 7 0.0201
26 HERPES DERMATITIS 4 0.0198
27 FUNGATING WOUND 1 0.0192
28 SYSTEMIC IMMUNE ACTIVATION 1 0.0189
29 METASTASES TO GALLBLADDER 1 0.0185
30 MENINGOENCEPHALITIS HERPETIC 6 0.0134
31 AUTOIMMUNE DERMATITIS 2 0.0132
32 DERMATITIS HERPETIFORMIS 3 0.0123
33 IATROGENIC INFECTION 1 0.0122
34 SPLENIC NECROSIS 1 0.0116
35 MANDIBULAR MASS 1 0.0114
36 HERPES SIMPLEX MENINGOENCEPHALITIS 1 0.0112
37 NEUROENDOCRINE CARCINOMA OF THE SKIN 11 0.0112
38 AUTOIMMUNE COLITIS 7 0.0109
39 BAND NEUTROPHIL COUNT INCREASED 2 0.0103
40 MEDICAL OBSERVATION 1 0.0093
41 AUTOIMMUNE NEPHRITIS 2 0.0091
42 AUTOIMMUNE LUNG DISEASE 1 0.0085
43 AUTOIMMUNE HYPOTHYROIDISM 2 0.0084
44 GLOMERULONEPHRITIS PROLIFERATIVE 3 0.0083
45 MORPHOEA 4 0.0083
46 ANGIOSARCOMA METASTATIC 1 0.0082
47 CYTOMEGALOVIRUS GASTRITIS 2 0.0079
48 EXTERNAL EAR CELLULITIS 1 0.0079
49 MALIGNANT FIBROUS HISTIOCYTOMA 1 0.0074
50 LYMPHOCYTIC HYPOPHYSITIS 2 0.0072
51 GASTROINTESTINAL MUCOSAL NECROSIS 1 0.0069
52 DERMO-HYPODERMITIS 4 0.0067
53 BASOSQUAMOUS CARCINOMA 1 0.0067
54 IMMUNE-MEDIATED NEUROPATHY 1 0.0065
55 HERPES VIRUS INFECTION 37 0.0064
56 VASCULAR FRAGILITY 1 0.0064
57 CHONDROSARCOMA 1 0.0063
58 METASTASES TO RETROPERITONEUM 1 0.0059
59 SMALL INTESTINE ADENOCARCINOMA 1 0.0056
60 RADIATION PROCTITIS 1 0.0054
61 GRANULOMATOUS LYMPHADENITIS 1 0.0053
62 HERPES SIMPLEX REACTIVATION 2 0.0052
63 MALIGNANT MELANOMA 69 0.0051
64 VITILIGO 12 0.0051
65 DROPPED HEAD SYNDROME 2 0.0051
66 LEUKODERMA 1 0.0050
67 MALIGNANT MELANOMA STAGE III 1 0.0049
68 NASAL HERPES 1 0.0049
69 CUTANEOUS LYMPHOMA 1 0.0049
70 TUMOUR ASSOCIATED FEVER 2 0.0049
71 C3 GLOMERULOPATHY 1 0.0048
72 RENAL PAPILLARY NECROSIS 1 0.0047
73 OROANTRAL FISTULA 1 0.0046
74 TUMOUR PSEUDOPROGRESSION 5 0.0046
75 IMMUNE-MEDIATED ADVERSE REACTION 7 0.0046
76 PARANASAL SINUS INFLAMMATION 1 0.0045
77 RESPIRATORY FATIGUE 1 0.0043
78 HERPES SIMPLEX 28 0.0043
79 ORAL PUSTULE 1 0.0043
80 TUMOUR HAEMORRHAGE 12 0.0042
81 HERPES SIMPLEX HEPATITIS 1 0.0042
82 TUMOUR HYPERPROGRESSION 1 0.0040
83 SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED 1 0.0039
84 CHEST WALL HAEMATOMA 1 0.0039
85 METASTASES TO SKIN 4 0.0039
86 INFESTATION 1 0.0039
87 THERAPY PARTIAL RESPONDER 60 0.0038
88 TUMOUR PAIN 5 0.0038
89 TUMOUR RUPTURE 2 0.0036
90 BIOPSY KIDNEY 1 0.0035
91 WOUND SEPSIS 1 0.0035
92 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 1 0.0034
93 CREATININE URINE INCREASED 1 0.0033
94 GENITAL HERPES 5 0.0033
95 INJECTION SITE CELLULITIS 6 0.0032
96 WOUND INFECTION PSEUDOMONAS 1 0.0032
97 CENTRAL NERVOUS SYSTEM INFLAMMATION 1 0.0030
98 PERIVASCULAR DERMATITIS 1 0.0030
99 GASTROENTERITIS EOSINOPHILIC 1 0.0029
100 TUMOUR FLARE 2 0.0029
101 INTERCEPTED PRODUCT ADMINISTRATION ERROR 22 0.0029
102 SOFT TISSUE SARCOMA 1 0.0029
103 INJECTION SITE EROSION 1 0.0028
104 TUMOUR NECROSIS 3 0.0028
105 SMALL CELL LUNG CANCER METASTATIC 1 0.0028
106 SKIN HYPOPIGMENTATION 5 0.0028
107 LOCAL REACTION 2 0.0027
108 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 89 0.0026
109 IMMUNE-MEDIATED ARTHRITIS 1 0.0026
110 IMMUNE-MEDIATED PANCREATITIS 1 0.0026
111 INJECTION SITE PUSTULE 1 0.0026
112 METASTATIC LYMPHOMA 1 0.0026
113 NEUTROPHILIC DERMATOSIS 1 0.0025
114 BREAST CANCER RECURRENT 8 0.0025
115 HYPOPHYSITIS 5 0.0025
116 METASTASES TO THE MEDIASTINUM 1 0.0024
117 WOUND INFECTION BACTERIAL 1 0.0024
118 ORAL HERPES 47 0.0024
119 GLUCOCORTICOID DEFICIENCY 1 0.0024
120 CUTANEOUS SARCOIDOSIS 1 0.0023
121 SYSTOLIC HYPERTENSION 1 0.0023
122 INTERCEPTED PRODUCT SELECTION ERROR 3 0.0023
123 LYMPH GLAND INFECTION 1 0.0022
124 REFUSAL OF TREATMENT BY RELATIVE 1 0.0022
125 GALLBLADDER CHOLESTEROLOSIS 1 0.0022
126 OCCUPATIONAL EXPOSURE TO PRODUCT 14 0.0022
127 BODY MASS INDEX DECREASED 1 0.0022
128 INJECTION SITE ULCER 2 0.0021
129 LYMPHOCYTIC INFILTRATION 2 0.0020
130 AUTOIMMUNE PANCREATITIS 1 0.0020
131 SPLENIC HAEMORRHAGE 1 0.0020
132 VESTIBULAR NEURONITIS 1 0.0019
133 RASH VESICULAR 9 0.0019
134 SQUAMOUS CELL CARCINOMA OF SKIN 11 0.0018
135 PSEUDOLYMPHOMA 1 0.0018
136 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
137 APNOEIC ATTACK 1 0.0018
138 SARCOMA 2 0.0018
139 RADIATION NECROSIS 1 0.0017
140 OPHTHALMIC HERPES SIMPLEX 1 0.0017
141 RADIATION SKIN INJURY 2 0.0017
142 EJECTION FRACTION 1 0.0017
143 LYMPHATIC DISORDER 1 0.0017
144 POST PROCEDURAL INFLAMMATION 1 0.0016
145 ARTERITIS 1 0.0016
146 SEROMA 2 0.0016
147 BLOOD CORTISOL DECREASED 1 0.0016
148 CHORIORETINITIS 1 0.0016
149 ENTEROCOCCUS TEST POSITIVE 1 0.0015
150 PRODUCT STORAGE ERROR 134 0.0015
151 TRIPLE NEGATIVE BREAST CANCER 1 0.0015
152 INFLAMMATORY PAIN 1 0.0015
153 INJECTION SITE NECROSIS 3 0.0015
154 T-LYMPHOCYTE COUNT DECREASED 1 0.0015
155 STASIS DERMATITIS 1 0.0015
156 KERATOACANTHOMA 1 0.0015
157 SOFT TISSUE NECROSIS 1 0.0015
158 GRANULOMA 5 0.0014
159 INJECTION SITE INFLAMMATION 7 0.0014
160 GLOMERULONEPHRITIS MINIMAL LESION 1 0.0014
161 PULMONARY SEPSIS 2 0.0014
162 IMPETIGO 2 0.0013
163 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
164 ASPIRATION PLEURAL CAVITY 1 0.0013
165 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 1 0.0013
166 LYMPHANGITIS 1 0.0012
167 EXCESSIVE GRANULATION TISSUE 1 0.0012
168 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
169 PANNICULITIS 3 0.0012
170 ENTEROCOCCAL SEPSIS 1 0.0012
171 PSEUDOMONAS TEST POSITIVE 1 0.0012
172 VENA CAVA THROMBOSIS 2 0.0012
173 METASTASES TO LYMPH NODES 8 0.0012
174 HEPATIC HAEMORRHAGE 1 0.0012
175 INJECTION SITE OEDEMA 2 0.0012
176 METASTATIC NEOPLASM 5 0.0012
177 INJECTION SITE VESICLES 7 0.0012
178 HEPATIC LESION 5 0.0012
179 THERAPY NON-RESPONDER 51 0.0011
180 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
181 OROPHARYNGEAL CANDIDIASIS 1 0.0011
182 IMMUNE-MEDIATED ENTEROCOLITIS 4 0.0011
183 INTERCEPTED MEDICATION ERROR 5 0.0011
184 CANCER SURGERY 1 0.0010
185 INJECTION SITE SCAB 1 0.0010
186 ONCOLOGIC COMPLICATION 1 0.0010
187 EPIDERMAL NECROSIS 1 0.0010
188 LYMPHADENECTOMY 1 0.0010
189 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
190 INFLUENZA LIKE ILLNESS 84 0.0010
191 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
192 IMMUNE-MEDIATED DERMATITIS 1 0.0010
193 CAPILLARY LEAK SYNDROME 2 0.0010
194 EMBOLISM 8 0.0010
195 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
196 BLAST CELL COUNT INCREASED 1 0.0010
197 METASTASES TO PLEURA 1 0.0010
198 IRIDOCYCLITIS 3 0.0009
199 PRODUCT NAME CONFUSION 1 0.0009
200 PRODUCT SELECTION ERROR 1 0.0009
201 VANISHING BILE DUCT SYNDROME 1 0.0009
202 PULMONARY SARCOIDOSIS 1 0.0009
203 IMMUNE-MEDIATED HYPOTHYROIDISM 1 0.0009
204 ARTERIAL HAEMORRHAGE 1 0.0009
205 METASTASES TO LUNG 10 0.0009
206 MUCOSAL HAEMORRHAGE 1 0.0009
207 AUTOIMMUNE HEPATITIS 6 0.0009
208 LIP ULCERATION 1 0.0009
209 HOSPICE CARE 8 0.0008
210 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
211 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
212 ERYSIPELAS 4 0.0008
213 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
214 SKIN NECROSIS 4 0.0008
215 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
216 HERPES OPHTHALMIC 1 0.0008
217 OESOPHAGEAL HAEMORRHAGE 1 0.0008
218 SKIN MASS 5 0.0007
219 INJECTION SITE DISCHARGE 4 0.0007
220 LYMPHOEDEMA 5 0.0007
221 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
222 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
223 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
224 NECK MASS 2 0.0007
225 CEREBELLAR HAEMORRHAGE 1 0.0007
226 TYPE 1 DIABETES MELLITUS 4 0.0007
227 PEMPHIGOID 5 0.0007
228 EYE ALLERGY 1 0.0006
229 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
230 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
231 CHILLS 73 0.0006
232 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
233 BACTERIAL SEPSIS 2 0.0006
234 INJECTION SITE INFECTION 2 0.0006
235 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
236 METASTASES TO SPINE 2 0.0006
237 MALIGNANT PLEURAL EFFUSION 1 0.0006
238 OTORRHOEA 1 0.0006
239 PSEUDOMONAL SEPSIS 1 0.0006
240 BREAST DISCHARGE 1 0.0006
241 ALOPECIA AREATA 1 0.0006
242 ERYTHEMA NODOSUM 2 0.0006
243 EMBOLIC STROKE 2 0.0006
244 APPLICATION SITE DISCOMFORT 1 0.0006
245 BODY TEMPERATURE ABNORMAL 1 0.0005
246 DISORGANISED SPEECH 1 0.0005
247 LIP DISORDER 1 0.0005
248 HYPOPROTEINAEMIA 1 0.0005
249 RETINAL OEDEMA 1 0.0005
250 ARTERIAL THROMBOSIS 1 0.0005
251 ATROPHY 1 0.0005
252 EARLY SATIETY 1 0.0005
253 SKIN CANCER 11 0.0005
254 GENE MUTATION 1 0.0005
255 CYTOKINE RELEASE SYNDROME 10 0.0005
256 IMMUNE-MEDIATED HEPATITIS 1 0.0005
257 HYPERURICAEMIA 2 0.0005
258 POLYCYTHAEMIA 1 0.0005
259 INJECTION SITE DISCOMFORT 5 0.0005
260 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
261 HYPERPHOSPHATAEMIA 1 0.0005
262 WOUND INFECTION 5 0.0005
263 PRODUCT LOT NUMBER ISSUE 1 0.0005
264 INFECTIOUS MONONUCLEOSIS 1 0.0004
265 SKIN INFECTION 5 0.0004
266 MENINGITIS ASEPTIC 2 0.0004
267 INJURY ASSOCIATED WITH DEVICE 9 0.0004
268 METASTASES TO MENINGES 1 0.0004
269 SKIN LESION 12 0.0004
270 CYTOMEGALOVIRUS COLITIS 1 0.0004
271 LICHEN PLANUS 1 0.0004
272 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
273 COLORECTAL CANCER METASTATIC 1 0.0004
274 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
275 METASTASIS 3 0.0004
276 PYREXIA 144 0.0004
277 RASH PUSTULAR 3 0.0004
278 GLOMERULONEPHRITIS 1 0.0004
279 BREATH SOUNDS ABNORMAL 2 0.0004
280 INJECTION SITE ABSCESS 1 0.0004
281 CELLULITIS 20 0.0004
282 MENTAL STATUS CHANGES 11 0.0004
283 URINARY TRACT INFECTION BACTERIAL 1 0.0004
284 LYMPHADENOPATHY 14 0.0004
285 DERMATOMYOSITIS 1 0.0004
286 BLOOD CHLORIDE DECREASED 1 0.0004
287 EJECTION FRACTION DECREASED 6 0.0004
288 FAILURE TO THRIVE 2 0.0004
289 MIGRAINE WITH AURA 1 0.0004
290 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
291 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
292 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
293 RASH MORBILLIFORM 1 0.0004
294 MACULE 1 0.0004
295 SKIN TOXICITY 2 0.0004
296 OXYGEN SATURATION ABNORMAL 1 0.0004
297 PERONEAL NERVE PALSY 2 0.0004
298 COMA SCALE ABNORMAL 1 0.0003
299 HAEMOTHORAX 1 0.0003
300 RALES 2 0.0003
301 GASTROINTESTINAL NECROSIS 1 0.0003
302 STRIDOR 1 0.0003
303 URINE ANALYSIS ABNORMAL 1 0.0003
304 BLOOD CULTURE POSITIVE 1 0.0003
305 DIABETIC KETOACIDOSIS 8 0.0003
306 ADRENAL INSUFFICIENCY 4 0.0003
307 MASTICATION DISORDER 1 0.0003
308 FIBROSIS 1 0.0003
309 PIGMENTATION DISORDER 2 0.0003
310 NASAL DRYNESS 2 0.0003
311 INVESTIGATION 1 0.0003
312 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
313 TRANSAMINASES INCREASED 7 0.0003
314 POLYMYALGIA RHEUMATICA 1 0.0003
315 ULCER 5 0.0003
316 ACCIDENTAL EXPOSURE TO PRODUCT 32 0.0003
317 PORTAL VEIN THROMBOSIS 1 0.0003
318 AUTOIMMUNE DISORDER 3 0.0003
319 INCORRECT PRODUCT STORAGE 4 0.0003
320 SYNCOPE 30 0.0003
321 NEPHRITIS 1 0.0003
322 WOUND COMPLICATION 1 0.0003
323 COLITIS 11 0.0003
324 ENCEPHALITIS 2 0.0003
325 DISEASE PROGRESSION 34 0.0003
326 HYPOXIA 10 0.0003
327 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
328 RENAL TRANSPLANT 1 0.0003
329 MONOCYTE COUNT INCREASED 1 0.0003
330 HEPATITIS 7 0.0003
331 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
332 HEPATIC NECROSIS 1 0.0003
333 INJECTION SITE RASH 8 0.0003
334 GASTRIC HAEMORRHAGE 3 0.0003
335 OFF LABEL USE 227 0.0003
336 PROCEDURAL HAEMORRHAGE 1 0.0003
337 WOUND SECRETION 1 0.0003
338 TRIGEMINAL NEURALGIA 1 0.0002
339 GALLBLADDER OPERATION 1 0.0002
340 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
341 PERIPHERAL ISCHAEMIA 1 0.0002
342 INTERCEPTED PRODUCT PREPARATION ERROR 3 0.0002
343 INJECTION SITE EXTRAVASATION 3 0.0002
344 LEG AMPUTATION 1 0.0002
345 CONGESTIVE CARDIOMYOPATHY 1 0.0002
346 SECRETION DISCHARGE 3 0.0002
347 SKIN PLAQUE 2 0.0002
348 SKIN ULCER 6 0.0002
349 PURPURA 2 0.0002
350 PAPILLOEDEMA 1 0.0002
351 UVEITIS 3 0.0002
352 LEUKOCYTOSIS 4 0.0002
353 DRUG EFFECT DELAYED 1 0.0002
354 INJECTION SITE PAPULE 1 0.0002
355 LOCALISED OEDEMA 1 0.0002
356 ARTHRITIS INFECTIVE 1 0.0002
357 GASTRITIS EROSIVE 1 0.0002
358 PERFORMANCE STATUS DECREASED 1 0.0002
359 SKIN REACTION 3 0.0002
360 SQUAMOUS CELL CARCINOMA 2 0.0002
361 LYMPHOPENIA 3 0.0002
362 COLITIS MICROSCOPIC 1 0.0002
363 SARCOIDOSIS 1 0.0002
364 RENAL TUBULAR NECROSIS 2 0.0002
365 STAPHYLOCOCCAL SEPSIS 1 0.0002
366 NEOPLASM PROGRESSION 7 0.0002
367 CORONARY ARTERY STENOSIS 1 0.0002
368 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
369 TRISMUS 1 0.0002
370 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
371 PERIORBITAL OEDEMA 1 0.0002
372 BASAL CELL CARCINOMA 3 0.0002
373 BLOOD LACTIC ACID INCREASED 1 0.0002
374 POLYARTHRITIS 1 0.0002
375 INJECTION SITE HAEMORRHAGE 15 0.0002
376 FOOD POISONING 1 0.0002
377 BREAST CANCER METASTATIC 2 0.0002
378 CHEILITIS 1 0.0002
379 METASTASES TO BONE 3 0.0002
380 DEAFNESS UNILATERAL 1 0.0002
381 RASH MACULO-PAPULAR 4 0.0002
382 NECROSIS 1 0.0002
383 INTRACRANIAL PRESSURE INCREASED 1 0.0002
384 INJECTION SITE ERYTHEMA 22 0.0002
385 NEUTROPHILIA 1 0.0002
386 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
387 MYOCARDITIS 2 0.0002
388 HERPES ZOSTER 10 0.0002
389 NEOPLASM 2 0.0002
390 EYELID OEDEMA 2 0.0002
391 EOSINOPHILIA 3 0.0002
392 METASTASES TO LIVER 3 0.0002
393 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
394 ODYNOPHAGIA 1 0.0002
395 GANGRENE 1 0.0002
396 INJECTION SITE PRURITUS 11 0.0002
397 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
398 ADVERSE EVENT 15 0.0002
399 HAIR COLOUR CHANGES 2 0.0002
400 INJECTION SITE PAIN 49 0.0002
401 INJECTION SITE IRRITATION 2 0.0002
402 INFLAMMATION 8 0.0002
403 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
404 PRODUCT PREPARATION ISSUE 1 0.0002
405 IMMUNE SYSTEM DISORDER 2 0.0002
406 WALKING AID USER 1 0.0002
407 SARS-COV-2 TEST POSITIVE 2 0.0002
408 CARDIAC FAILURE ACUTE 1 0.0001
409 TERMINAL STATE 1 0.0001
410 RASH PRURITIC 8 0.0001
411 ECCHYMOSIS 1 0.0001
412 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
413 HYPERTRANSAMINASAEMIA 1 0.0001
414 HYPONATRAEMIA 8 0.0001
415 PAPULE 1 0.0001
416 SINUS TACHYCARDIA 2 0.0001
417 FEAR OF INJECTION 1 0.0001
418 DERMATITIS BULLOUS 1 0.0001
419 INTENTIONAL UNDERDOSE 1 0.0001
420 HYPOPHOSPHATAEMIA 1 0.0001
421 SEPSIS 15 0.0001
422 GENERAL SYMPTOM 1 0.0001
423 UNEVALUABLE EVENT 10 0.0001
424 STOMATITIS 8 0.0001
425 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
426 HEPATOCELLULAR CARCINOMA 1 0.0001
427 AORTIC ANEURYSM 1 0.0001
428 HAEMODYNAMIC INSTABILITY 1 0.0001
429 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
430 HYPOALBUMINAEMIA 1 0.0001
431 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
432 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
433 POST PROCEDURAL INFECTION 1 0.0001
434 NEUTROPHIL COUNT DECREASED 5 0.0001
435 HICCUPS 1 0.0001
436 ESCHERICHIA INFECTION 1 0.0001
437 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
438 DEATH 104 0.0001
439 SECOND PRIMARY MALIGNANCY 1 0.0001
440 SCAR 2 0.0001
441 CARDIAC OPERATION 1 0.0001
442 RASH GENERALISED 3 0.0001
443 HAEMATOMA 3 0.0001
444 MYOPATHY 1 0.0001
445 ORTHOSTATIC HYPOTENSION 2 0.0001
446 IMMUNOSUPPRESSION 1 0.0001
447 LUNG INFILTRATION 1 0.0001
448 LYMPHOCYTE COUNT DECREASED 2 0.0001
449 RESPIRATORY RATE INCREASED 1 0.0001
450 MYOSITIS 1 0.0001
451 GASTROINTESTINAL CARCINOMA 1 0.0001
452 OPTIC NEURITIS 1 0.0001
453 HIDRADENITIS 1 0.0001
454 PNEUMONIA BACTERIAL 1 0.0001
455 UROSEPSIS 1 0.0001
456 IRON DEFICIENCY ANAEMIA 1 0.0001
457 CONJUNCTIVITIS 2 0.0001
458 ERYTHEMA MULTIFORME 1 0.0001
459 APPENDICITIS 1 0.0001
460 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
461 PRODUCT PACKAGING ISSUE 1 0.0001
462 EYE INFLAMMATION 1 0.0001
463 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
464 RASH ERYTHEMATOUS 5 0.0001
465 AFFECT LABILITY 1 0.0001
466 EAR PAIN 2 0.0001
467 LABORATORY TEST ABNORMAL 3 0.0001
468 FATIGUE 79 0.0001
469 HAEMATOCRIT DECREASED 2 0.0001
470 ILL-DEFINED DISORDER 6 0.0001
471 INJECTION SITE WARMTH 2 0.0001
472 TENDERNESS 1 0.0001
473 WEIGHT FLUCTUATION 1 0.0001
474 DERMATITIS 2 0.0001
475 TRANSFUSION 1 0.0001
476 FOLLICULITIS 1 0.0001
477 MYALGIA 16 0.0001
478 PLATELET COUNT DECREASED 10 0.0001
479 METABOLIC ACIDOSIS 3 0.0001
480 LIVER FUNCTION TEST INCREASED 2 0.0001
481 POOR QUALITY SLEEP 2 0.0001
482 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
483 SKIN LACERATION 1 0.0001
484 OESOPHAGITIS 1 0.0001
485 IMPAIRED HEALING 3 0.0001
486 INJECTION SITE NODULE 1 0.0001
487 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
488 NERVE INJURY 1 0.0001
489 RASH PAPULAR 2 0.0001
490 OCULAR DISCOMFORT 1 0.0001
491 EYE INFECTION 1 0.0001
492 IMPAIRED DRIVING ABILITY 1 0.0001
493 DERMATITIS CONTACT 1 0.0001
494 CHOLECYSTECTOMY 1 0.0001
495 LETHARGY 5 0.0001
496 DELIRIUM 3 0.0001
497 VASCULITIS 1 0.0001
498 BACTERAEMIA 1 0.0001
499 CHOLECYSTITIS 1 0.0001
500 ANAEMIA 16 0.0001
501 DEHYDRATION 11 0.0001
502 RESPIRATORY FAILURE 6 0.0001
503 HYPERCALCAEMIA 1 0.0001
504 NEUTROPENIA 11 0.0001
505 PNEUMONIA ASPIRATION 2 0.0001
506 INJECTION SITE DISCOLOURATION 1 0.0001
507 HYPOTENSION 16 0.0001
508 DERMATITIS ALLERGIC 1 0.0001
509 VOMITING 37 0.0001
510 ADVERSE DRUG REACTION 7 0.0001
511 DEEP VEIN THROMBOSIS 5 0.0001
512 NODULE 1 0.0001
513 BLOOD CREATININE INCREASED 5 0.0001
514 TOOTH INFECTION 1 0.0001
515 DISORIENTATION 3 0.0001
516 RASH 33 0.0001
517 ADVERSE REACTION 1 0.0001
518 PAIN OF SKIN 2 0.0001
519 BLOOD BILIRUBIN INCREASED 2 0.0001
520 PULMONARY EMBOLISM 7 0.0001
521 TACHYPNOEA 1 0.0001
522 PNEUMONITIS 2 0.0001
523 HEPATIC ENZYME INCREASED 5 0.0001
524 ACUTE HEPATIC FAILURE 1 0.0001
525 PROCEDURAL PAIN 2 0.0001
526 FEELING COLD 2 0.0001
527 HYPOMAGNESAEMIA 1 0.0001
528 PANCYTOPENIA 4 0.0001
529 WOUND 2 0.0001
530 MASS 1 0.0001
531 BLISTER 4 0.0001
532 THERAPY INTERRUPTED 5 0.0001
533 RED BLOOD CELL COUNT DECREASED 2 0.0001
534 CARDIOGENIC SHOCK 1 0.0001
535 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
536 HYPERTHYROIDISM 1 0.0001
537 GASTROENTERITIS 1 0.0001
538 UNDERDOSE 5 0.0001
539 ERYTHEMA 14 0.0001
540 RENAL FAILURE 9 0.0001
541 SKIN HAEMORRHAGE 1 0.0001
542 COLON CANCER 1 0.0001
543 IMMUNODEFICIENCY 1 0.0001
544 DRUG DOSE OMISSION 11 0.0001
545 APHASIA 2 0.0001
546 LACRIMATION INCREASED 2 0.0001
547 PLEURAL EFFUSION 4 0.0001
548 OEDEMA PERIPHERAL 8 0.0001
549 VERTIGO 4 0.0001
550 DRUG DISPENSING ERROR 1 0.0001
551 HIP ARTHROPLASTY 1 0.0001
552 MUSCULOSKELETAL CHEST PAIN 1 0.0001
553 NAUSEA 51 0.0001
554 ACUTE MYELOID LEUKAEMIA 1 0.0001
555 SWELLING 6 0.0001
556 NERVOUS SYSTEM DISORDER 2 0.0001
557 PRODUCT USE COMPLAINT 1 0.0001
558 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
559 HEAD INJURY 2 0.0001
560 NEUROPATHY PERIPHERAL 6 0.0001
561 DISEASE RECURRENCE 3 0.0001
562 THROMBOCYTOPENIA 7 0.0001
563 CONFUSIONAL STATE 10 0.0001
564 MALAISE 27 0.0001
565 DRUG LEVEL INCREASED 1 0.0001
566 DECREASED APPETITE 14 0.0001
567 EXPIRED PRODUCT ADMINISTERED 2 0.0001
568 CYTOMEGALOVIRUS INFECTION 1 0.0001
569 COAGULOPATHY 1 0.0001
570 URINARY RETENTION 2 0.0001
571 NEOPLASM MALIGNANT 4 0.0001
572 BLOOD UREA INCREASED 1 0.0001
573 PERICARDITIS 1 0.0001
574 ACUTE KIDNEY INJURY 9 0.0001
575 PAIN 36 0.0001
576 RASH MACULAR 2 0.0001
577 HYPERKALAEMIA 2 0.0001
578 BRADYCARDIA 3 0.0001
579 DRUG ERUPTION 1 0.0001
580 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
581 THIRST 1 0.0001
582 GOUT 1 0.0001
583 MOBILITY DECREASED 4 0.0001
584 OSTEOMYELITIS 1 0.0001
585 DRUG EFFECT INCOMPLETE 2 0.0001
586 RESTLESS LEGS SYNDROME 1 0.0001
587 BONE DISORDER 1 0.0001
588 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
589 EYE SWELLING 2 0.0001
590 PHOTOPHOBIA 1 0.0001
591 BLOOD SODIUM DECREASED 1 0.0001
592 MUSCULAR WEAKNESS 6 0.0001
593 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
594 POST PROCEDURAL COMPLICATION 1 0.0001
595 ACUTE RESPIRATORY FAILURE 1 0.0001
596 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
597 ERUCTATION 1 0.0001
598 PLASMA CELL MYELOMA 2 0.0001
599 SKIN FISSURES 1 0.0001
600 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
601 SINUS DISORDER 1 0.0001
602 UPPER LIMB FRACTURE 1 0.0001
603 CARDIAC FAILURE 4 0.0000
604 CARDIAC FAILURE CONGESTIVE 4 0.0000
605 FEEDING DISORDER 1 0.0000
606 BODY TEMPERATURE INCREASED 1 0.0000
607 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
608 MOUTH ULCERATION 1 0.0000
609 EATING DISORDER 1 0.0000
610 SEPTIC SHOCK 2 0.0000
611 PRODUCT DISPENSING ERROR 1 0.0000
612 COVID-19 8 0.0000
613 INFUSION RELATED REACTION 3 0.0000
614 TACHYCARDIA 4 0.0000
615 TOOTH DISORDER 1 0.0000
616 HEPATOTOXICITY 1 0.0000
617 ORAL PAIN 1 0.0000
618 HEADACHE 28 0.0000
619 GASTROINTESTINAL DISORDER 4 0.0000
620 CHROMATURIA 1 0.0000
621 SKIN IRRITATION 2 0.0000
622 INJECTION SITE REACTION 3 0.0000
623 SKIN DISCOLOURATION 2 0.0000
624 DIARRHOEA 28 0.0000
625 SEIZURE 5 0.0000
626 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
627 PNEUMONIA 14 0.0000
628 DYSPHAGIA 4 0.0000
629 MULTIPLE SCLEROSIS 2 0.0000
630 PRESYNCOPE 1 0.0000
631 ENCEPHALOPATHY 1 0.0000
632 ABASIA 1 0.0000
633 AGEUSIA 1 0.0000
634 DRY EYE 2 0.0000
635 INJECTION SITE SWELLING 3 0.0000
636 HYPOPHAGIA 1 0.0000
637 HOSPITALISATION 6 0.0000
638 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
639 HYPERHIDROSIS 5 0.0000
640 UNRESPONSIVE TO STIMULI 1 0.0000
641 NERVOUSNESS 2 0.0000
642 HAEMORRHAGE 4 0.0000
643 DEAFNESS 1 0.0000
644 ECZEMA 2 0.0000
645 ARTHRITIS 3 0.0000
646 FEAR 1 0.0000
647 DRY MOUTH 3 0.0000
648 THROAT TIGHTNESS 1 0.0000
649 LIMB INJURY 1 0.0000
650 PRODUCT QUALITY ISSUE 5 0.0000
651 CARDIAC ARREST 3 0.0000
652 HAEMOPTYSIS 1 0.0000
653 RENAL IMPAIRMENT 3 0.0000
654 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
655 PAIN IN JAW 1 0.0000
656 HYPERSOMNIA 1 0.0000
657 INFECTION 5 0.0000
658 ABDOMINAL PAIN 8 0.0000
659 DYSSTASIA 1 0.0000
660 ASCITES 1 0.0000
661 PAIN IN EXTREMITY 10 0.0000
662 ACUTE MYOCARDIAL INFARCTION 1 0.0000
663 URINARY INCONTINENCE 1 0.0000
664 WHEEZING 2 0.0000
665 CATARACT 2 0.0000
666 HEPATIC FAILURE 1 0.0000
667 EPILEPSY 1 0.0000
668 DRUG ADMINISTRATION ERROR 1 0.0000
669 VISUAL IMPAIRMENT 4 0.0000
670 COUGH 9 0.0000
671 PRODUCT USE ISSUE 6 0.0000
672 DRUG-INDUCED LIVER INJURY 1 0.0000
673 CYSTITIS 1 0.0000
674 HYPOTHYROIDISM 1 0.0000
675 ARTHRALGIA 13 0.0000
676 HIP FRACTURE 1 0.0000
677 NIGHT SWEATS 1 0.0000
678 EYE DISORDER 1 0.0000
679 FEBRILE NEUTROPENIA 2 0.0000
680 TREMOR 5 0.0000
681 DYSPNOEA 17 0.0000
682 SKIN DISORDER 1 0.0000
683 DRY SKIN 4 0.0000
684 SOMNOLENCE 6 0.0000
685 TOXICITY TO VARIOUS AGENTS 5 0.0000
686 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
687 ASTHENIA 11 0.0000
688 HAEMATURIA 1 0.0000
689 ILLNESS 3 0.0000
690 PRURITUS 11 0.0000
691 INJURY 2 0.0000
692 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
693 C-REACTIVE PROTEIN INCREASED 1 0.0000
694 BRONCHITIS 2 0.0000
695 DYSGEUSIA 2 0.0000
696 INFLUENZA 3 0.0000
697 DYSARTHRIA 1 0.0000
698 HALLUCINATION 2 0.0000
699 INTESTINAL OBSTRUCTION 1 0.0000
700 DIABETES MELLITUS 2 0.0000
701 PERIPHERAL SWELLING 4 0.0000
702 PARAESTHESIA 4 0.0000
703 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
704 OSTEOPOROSIS 1 0.0000
705 DIZZINESS 12 0.0000
706 RHABDOMYOLYSIS 1 0.0000
707 ROAD TRAFFIC ACCIDENT 1 0.0000
708 CEREBROVASCULAR ACCIDENT 4 0.0000
709 DRUG INEFFECTIVE 31 0.0000
710 HYPOACUSIS 1 0.0000
711 BALANCE DISORDER 2 0.0000
712 MENTAL DISORDER 1 0.0000
713 ANGIOEDEMA 1 0.0000
714 COLITIS ULCERATIVE 1 0.0000
715 PULMONARY OEDEMA 1 0.0000
716 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
717 INCORRECT DOSE ADMINISTERED 5 0.0000
718 VISION BLURRED 3 0.0000
719 HYPOKALAEMIA 1 0.0000
720 OROPHARYNGEAL PAIN 2 0.0000
721 WEIGHT DECREASED 6 0.0000
722 CARDIAC DISORDER 2 0.0000
723 BLOOD GLUCOSE INCREASED 4 0.0000
724 ARRHYTHMIA 1 0.0000
725 OCULAR HYPERAEMIA 1 0.0000
726 MIGRAINE 2 0.0000
727 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
728 CONTUSION 2 0.0000
729 DRUG INTOLERANCE 2 0.0000
730 HYPOGLYCAEMIA 1 0.0000
731 ATRIAL FIBRILLATION 2 0.0000
732 LUNG DISORDER 1 0.0000
733 FLUSHING 2 0.0000
734 HAEMOGLOBIN DECREASED 2 0.0000
735 SPEECH DISORDER 1 0.0000
736 DRUG INTERACTION 3 0.0000
737 DRUG EFFECT DECREASED 1 0.0000
738 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
739 OEDEMA 1 0.0000
740 HAEMATOCHEZIA 1 0.0000
741 ARTHROPATHY 1 0.0000
742 MEDICATION ERROR 1 0.0000
743 NECK PAIN 1 0.0000
744 EYE PAIN 1 0.0000
745 BACK PAIN 4 0.0000
746 DYSPHONIA 1 0.0000
747 BONE PAIN 1 0.0000
748 DISCOMFORT 1 0.0000
749 FEELING HOT 1 0.0000
750 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
751 LOSS OF CONSCIOUSNESS 2 0.0000
752 RHINORRHOEA 1 0.0000
753 SWELLING FACE 1 0.0000
754 ALOPECIA 3 0.0000
755 FALL 5 0.0000
756 MEMORY IMPAIRMENT 2 0.0000
757 BURNING SENSATION 1 0.0000
758 SLEEP DISORDER 1 0.0000
759 HYPERTENSION 3 0.0000
760 HOT FLUSH 1 0.0000
761 CHRONIC KIDNEY DISEASE 1 0.0000
762 INJECTION SITE BRUISING 1 0.0000
763 COMPLETED SUICIDE 1 0.0000
764 MYOCARDIAL INFARCTION 2 0.0000
765 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
766 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
767 DEVICE ISSUE 1 0.0000
768 MUSCLE SPASMS 2 0.0000
769 NASOPHARYNGITIS 2 0.0000
770 HYPERSENSITIVITY 2 0.0000
771 GAIT DISTURBANCE 2 0.0000
772 PRODUCT DOSE OMISSION ISSUE 3 0.0000
773 HEART RATE INCREASED 1 0.0000
774 ABDOMINAL PAIN UPPER 2 0.0000
775 ABDOMINAL DISTENSION 1 0.0000
776 CONSTIPATION 2 0.0000
777 ASTHMA 1 0.0000
778 FEELING ABNORMAL 2 0.0000
779 INSOMNIA 2 0.0000
780 HYPOAESTHESIA 1 0.0000
781 CONDITION AGGRAVATED 2 0.0000
782 URTICARIA 1 0.0000
783 ABDOMINAL DISCOMFORT 1 0.0000
784 URINARY TRACT INFECTION 1 0.0000
785 CHEST PAIN 1 0.0000
786 ANXIETY 1 0.0000